Casinos Aren’t Enough as Native Tribe Makes Deal on Drug Patents
- Allergan to shift drug IP to shield from legal challenge
- ‘Our options beyond the casino are few and far between’
This article is for subscribers only.
For one Native American tribe, the money’s not in the casino anymore. Patents are the future.
On Friday, drugmaker Allergan Plc said it would transfer intellectual property on a blockbuster drug to the Saint Regis Mohawk Tribe, in order to avoid attacks on the medicine’s patents. For the tribe, it’s a new revenue stream that could lead to more down the road.